Allovir, Inc. Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Allovir, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2024.
- Allovir, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.77M, a 83.6% increase year-over-year.
- Allovir, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$149M, a 14.1% increase year-over-year.
- Allovir, Inc. annual Operating Income (Loss) for 2023 was -$200M, a 16.8% decline from 2022.
- Allovir, Inc. annual Operating Income (Loss) for 2022 was -$171M, a 0.82% decline from 2021.
- Allovir, Inc. annual Operating Income (Loss) for 2021 was -$170M, a 138% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)